Stock Comparison
ABT vs EW
Abbott Laboratories and Edwards Lifesciences Corp side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$163.94B
$52.27B
P/E (TTM)
26.4
48.6
Forward P/E
17.2
29.9
Price/Sales
3.6
8.3
Price/Book
3.2
5.0
EV/EBITDA
16.1
31.2
Dividend Yield
2.62%
—
Profitability
Net Margin
13.90%
17.40%
Operating Margin
13.50%
31.20%
Return on Equity
12.30%
10.50%
Return on Assets
5.59%
8.27%
Growth (YoY)
Revenue Growth
7.80%
16.70%
Earnings Growth
-19.70%
8.20%
Price & Risk
Beta
0.6
0.9
52-Week High
$135.34
$92.46
52-Week Low
$81.97
$72.30
Analyst Target
$116.54
$96.92
Compare ABT and EW your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.